Stephen I. Cohen

1 ta ish

Boston University

1. Phase I Trial of Anti‐PSMA Designer CAR‐T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2‐T Cell Pharmacodynamics as a Determinant of Clinical Response

   Richard P. Junghans, Qiangzhong Ma, Ritesh Rathore +8

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.130600